25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CEMENTOS (Cementos Bio-B) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cementos Bio-B together

I guess you are interested in Cementos Bio-B. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Cementos Bio-B’s Financial Insights
  • 📈 Technical Analysis (TA) – Cementos Bio-B’s Price Targets

I'm going to help you getting a better view of Cementos Bio-B. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cementos Bio-B

I send you an email if I find something interesting about Cementos Bio-B.

1. Quick Overview

1.1. Quick analysis of Cementos Bio-B (30 sec.)










1.2. What can you expect buying and holding a share of Cementos Bio-B? (30 sec.)

How much money do you get?

How much money do you get?
₱0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
₱1,044.55
Expected worth in 1 year
₱1,060.18
How sure are you?
96.6%

+ What do you gain per year?

Total Gains per Share
₱118.13
Return On Investment
7.4%

For what price can you sell your share?

Current Price per Share
₱1,600.00
Expected price per share
₱1,490 - ₱1,600
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cementos Bio-B (5 min.)




Live pricePrice per Share (EOD)
₱1,600.00
Intrinsic Value Per Share
₱-1,815.31 - ₱-2,235.51
Total Value Per Share
₱-770.76 - ₱-1,190.96

2.2. Growth of Cementos Bio-B (5 min.)




Is Cementos Bio-B growing?

Current yearPrevious yearGrowGrow %
How rich?$275.9m$257.9m$15.4m5.6%

How much money is Cementos Bio-B making?

Current yearPrevious yearGrowGrow %
Making money$6.8m$5.7m$1.1m16.3%
Net Profit Margin7.7%6.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Cementos Bio-B (5 min.)




2.4. Comparing to competitors in the Building Materials industry (5 min.)




  Industry Rankings (Building Materials)  


Richest
#118 / 208

Most Revenue
#122 / 208

Most Profit
#97 / 208
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cementos Bio-B?

Welcome investor! Cementos Bio-B's management wants to use your money to grow the business. In return you get a share of Cementos Bio-B.

First you should know what it really means to hold a share of Cementos Bio-B. And how you can make/lose money.

Speculation

The Price per Share of Cementos Bio-B is ₱1,600. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cementos Bio-B.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cementos Bio-B, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₱1,044.55. Based on the TTM, the Book Value Change Per Share is ₱3.91 per quarter. Based on the YOY, the Book Value Change Per Share is ₱34.89 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₱25.63 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cementos Bio-B.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.020.0%0.030.0%0.020.0%0.020.0%0.020.0%0.020.0%
Usd Book Value Change Per Share0.020.0%0.000.0%0.030.0%0.010.0%0.010.0%0.040.0%
Usd Dividend Per Share0.000.0%0.030.0%0.000.0%0.020.0%0.020.0%0.010.0%
Usd Total Gains Per Share0.020.0%0.030.0%0.040.0%0.030.0%0.020.0%0.050.0%
Usd Price Per Share1.52-1.13-0.65-0.83-0.79-0.82-
Price to Earnings Ratio17.03-10.96-10.75-13.25-17.75-17.67-
Price-to-Total Gains Ratio76.35-44.21-21.34-73.44-79.39-71.79-
Price to Book Ratio1.46-1.10-0.67-0.85-0.82-0.88-
Price-to-Total Gains Ratio76.35-44.21-21.34-73.44-79.39-71.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.6
Number of shares625
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.02
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.030.02
Gains per Quarter (625 shares)18.4614.15
Gains per Year (625 shares)73.8356.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1641064391747
2128201387934104
31922921211852161
42563928615769218
53204936019786275
638459434236103332
744868508276121389
851378582315138446
957788656354155503
1064198730394172560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.00.00.0100.0%19.00.00.0100.0%29.00.00.0100.0%29.00.00.0100.0%
Book Value Change Per Share2.02.00.050.0%8.02.01.072.7%14.04.01.073.7%23.05.01.079.3%23.05.01.079.3%
Dividend per Share4.00.00.0100.0%11.00.00.0100.0%19.00.00.0100.0%29.00.00.0100.0%29.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%11.00.00.0100.0%18.01.00.094.7%28.01.00.096.6%28.01.00.096.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cementos Bio-B compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--19.9523.906+411%34.889-43%14.892+34%6.890+190%36.019-45%
Book Value Per Share--1044.5541034.780+1%976.421+7%972.836+7%953.708+10%925.840+13%
Current Ratio--1.3091.411-7%1.546-15%1.465-11%1.626-20%1.695-23%
Debt To Asset Ratio--0.4700.465+1%0.474-1%0.480-2%0.473-1%0.475-1%
Debt To Equity Ratio--0.8880.871+2%0.904-2%0.928-4%0.902-2%0.911-2%
Dividend Per Share--0.01625.626-100%3.971-100%18.987-100%15.744-100%13.543-100%
Enterprise Value--158218483600.00061983068400.000+155%-59352430180.000+138%-16886603866.364+111%-18269312831.579+112%-5524452500.069+103%
Eps--22.37525.886-14%21.655+3%19.877+13%19.140+17%18.500+21%
Ev To Sales Ratio--0.4250.160+165%-0.169+140%-0.056+113%-0.063+115%-0.016+104%
Free Cash Flow Per Share---10.52549.499-121%1.689-723%27.400-138%19.120-155%19.208-155%
Free Cash Flow To Equity Per Share---10.52549.499-121%-5.915-44%14.582-172%0.088-12044%2.832-472%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2235.511----------
Intrinsic Value_10Y_min---1815.312----------
Intrinsic Value_1Y_max--61.395----------
Intrinsic Value_1Y_min--60.473----------
Intrinsic Value_3Y_max---33.047----------
Intrinsic Value_3Y_min---27.158----------
Intrinsic Value_5Y_max---389.727----------
Intrinsic Value_5Y_min---343.013----------
Market Cap422753587200.000+5%402831336600.000299600191900.000+34%172911506820.000+133%220169834679.091+83%208111584694.737+94%216050400982.690+86%
Net Profit Margin--0.0630.077-17%0.062+2%0.060+6%0.063+0%0.065-2%
Operating Margin----0%0.023-100%0.018-100%0.037-100%0.054-100%
Operating Ratio--1.5241.5310%1.534-1%1.562-2%1.572-3%1.560-2%
Pb Ratio1.532+5%1.4601.096+33%0.671+118%0.849+72%0.821+78%0.884+65%
Pe Ratio17.877+5%17.03510.958+55%10.754+58%13.254+29%17.745-4%17.674-4%
Price Per Share1600.000+5%1524.6001133.900+34%654.420+133%833.279+83%787.642+94%817.688+86%
Price To Free Cash Flow Ratio-38.004-5%-36.213-6.443-82%-16.327-55%-8.459-77%3.687-1082%5.233-792%
Price To Total Gains Ratio80.125+5%76.34944.209+73%21.345+258%73.437+4%79.389-4%71.793+6%
Quick Ratio--0.5770.559+3%0.635-9%0.593-3%0.620-7%0.657-12%
Return On Assets--0.0110.013-15%0.011-1%0.011+5%0.011+7%0.011+8%
Return On Equity--0.0210.025-14%0.022-1%0.021+4%0.020+7%0.020+7%
Total Gains Per Share--19.96929.532-32%38.860-49%33.879-41%22.634-12%49.562-60%
Usd Book Value--275993099.000273410727.250+1%257991017.000+7%257043639.818+7%251989669.000+10%244626474.862+13%
Usd Book Value Change Per Share--0.0200.004+411%0.035-43%0.015+34%0.007+190%0.036-45%
Usd Book Value Per Share--1.0451.035+1%0.976+7%0.973+7%0.954+10%0.926+13%
Usd Dividend Per Share--0.0000.026-100%0.004-100%0.019-100%0.016-100%0.014-100%
Usd Enterprise Value--158218483.60061983068.400+155%-59352430.180+138%-16886603.866+111%-18269312.832+112%-5524452.500+103%
Usd Eps--0.0220.026-14%0.022+3%0.020+13%0.019+17%0.019+21%
Usd Free Cash Flow---2780957.00013078603.000-121%446155.000-723%7239745.727-138%5051935.368-155%5075135.586-155%
Usd Free Cash Flow Per Share---0.0110.049-121%0.002-723%0.027-138%0.019-155%0.019-155%
Usd Free Cash Flow To Equity Per Share---0.0110.049-121%-0.006-44%0.015-172%0.000-12044%0.003-472%
Usd Market Cap422753587.200+5%402831336.600299600191.900+34%172911506.820+133%220169834.679+83%208111584.695+94%216050400.983+86%
Usd Price Per Share1.600+5%1.5251.134+34%0.654+133%0.833+83%0.788+94%0.818+86%
Usd Profit--5911881.0006839751.000-14%5721619.667+3%5394921.455+10%5139825.684+15%4942388.862+20%
Usd Revenue--93125527.00088678532.500+5%87806991.667+6%87535089.364+6%79112345.526+18%74623057.759+25%
Usd Total Gains Per Share--0.0200.030-32%0.039-49%0.034-41%0.023-12%0.050-60%
 EOD+5 -3MRQTTM+16 -21YOY+19 -193Y+23 -155Y+23 -1510Y+21 -17

3.3 Fundamental Score

Let's check the fundamental score of Cementos Bio-B based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.877
Price to Book Ratio (EOD)Between0-11.532
Net Profit Margin (MRQ)Greater than00.063
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.577
Current Ratio (MRQ)Greater than11.309
Debt to Asset Ratio (MRQ)Less than10.470
Debt to Equity Ratio (MRQ)Less than10.888
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.011
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Cementos Bio-B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.092
Ma 20Greater thanMa 501,575.000
Ma 50Greater thanMa 1001,566.104
Ma 100Greater thanMa 2001,518.402
OpenGreater thanClose1,600.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Cementos Bio-B

Cementos Bio Bio S.A. engages in the production and sale of cement, lime, and concrete products in Chile and internationally. The company operates through Cement and Lime segments. It offers ready-mixed concrete, gypsum, and limestone products. The company is also involved in the manufacture and sale of lime for use in the extraction of silver, gold, lithium, and iodine applications, as well as copper concentrators. Cementos Bio Bio S.A. was incorporated in 1957 and is based in Providencia, Chile.

Fundamental data was last updated by Penke on 2025-06-28 16:34:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cementos Bio-B earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • A Net Profit Margin of 6.3% means that $0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cementos Bio-B:

  • The MRQ is 6.3%. The company is making a profit. +1
  • The TTM is 7.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.3%TTM7.7%-1.3%
TTM7.7%YOY6.2%+1.5%
TTM7.7%5Y6.3%+1.4%
5Y6.3%10Y6.5%-0.2%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3%3.4%+2.9%
TTM7.7%3.9%+3.8%
YOY6.2%5.1%+1.1%
3Y6.0%4.5%+1.5%
5Y6.3%6.1%+0.2%
10Y6.5%5.7%+0.8%
4.3.1.2. Return on Assets

Shows how efficient Cementos Bio-B is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • 1.1% Return on Assets means that Cementos Bio-B generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cementos Bio-B:

  • The MRQ is 1.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.1%TTM1.3%-0.2%
TTM1.3%YOY1.1%+0.2%
TTM1.3%5Y1.1%+0.3%
5Y1.1%10Y1.1%+0.0%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1%0.7%+0.4%
TTM1.3%1.0%+0.3%
YOY1.1%1.3%-0.2%
3Y1.1%1.4%-0.3%
5Y1.1%1.5%-0.4%
10Y1.1%1.7%-0.6%
4.3.1.3. Return on Equity

Shows how efficient Cementos Bio-B is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • 2.1% Return on Equity means Cementos Bio-B generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cementos Bio-B:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.5%-0.4%
TTM2.5%YOY2.2%+0.3%
TTM2.5%5Y2.0%+0.5%
5Y2.0%10Y2.0%+0.0%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%1.3%+0.8%
TTM2.5%1.6%+0.9%
YOY2.2%2.3%-0.1%
3Y2.1%2.4%-0.3%
5Y2.0%2.7%-0.7%
10Y2.0%3.2%-1.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cementos Bio-B.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cementos Bio-B is operating .

  • Measures how much profit Cementos Bio-B makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cementos Bio-B:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.3%-2.3%
TTM-5Y3.7%-3.7%
5Y3.7%10Y5.4%-1.6%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM-7.8%-7.8%
YOY2.3%5.9%-3.6%
3Y1.8%5.6%-3.8%
5Y3.7%8.6%-4.9%
10Y5.4%8.8%-3.4%
4.3.2.2. Operating Ratio

Measures how efficient Cementos Bio-B is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Building Materials industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are $1.52 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cementos Bio-B:

  • The MRQ is 1.524. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.531. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.524TTM1.531-0.006
TTM1.531YOY1.534-0.004
TTM1.5315Y1.572-0.041
5Y1.57210Y1.560+0.012
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5241.619-0.095
TTM1.5311.467+0.064
YOY1.5341.031+0.503
3Y1.5621.217+0.345
5Y1.5721.075+0.497
10Y1.5601.036+0.524
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cementos Bio-B.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cementos Bio-B is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Building Materials industry mean).
  • A Current Ratio of 1.31 means the company has $1.31 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cementos Bio-B:

  • The MRQ is 1.309. The company is just able to pay all its short-term debts.
  • The TTM is 1.411. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.309TTM1.411-0.102
TTM1.411YOY1.546-0.136
TTM1.4115Y1.626-0.216
5Y1.62610Y1.695-0.069
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3091.393-0.084
TTM1.4111.412-0.001
YOY1.5461.465+0.081
3Y1.4651.494-0.029
5Y1.6261.527+0.099
10Y1.6951.450+0.245
4.4.3.2. Quick Ratio

Measures if Cementos Bio-B is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • A Quick Ratio of 0.58 means the company can pay off $0.58 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cementos Bio-B:

  • The MRQ is 0.577. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.559. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.559+0.018
TTM0.559YOY0.635-0.076
TTM0.5595Y0.620-0.061
5Y0.62010Y0.657-0.037
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5770.594-0.017
TTM0.5590.597-0.038
YOY0.6350.748-0.113
3Y0.5930.716-0.123
5Y0.6200.801-0.181
10Y0.6570.845-0.188
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cementos Bio-B.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cementos Bio-B assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cementos Bio-B to Building Materials industry mean.
  • A Debt to Asset Ratio of 0.47 means that Cementos Bio-B assets are financed with 47.0% credit (debt) and the remaining percentage (100% - 47.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cementos Bio-B:

  • The MRQ is 0.470. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.465. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.470TTM0.465+0.005
TTM0.465YOY0.474-0.009
TTM0.4655Y0.473-0.008
5Y0.47310Y0.475-0.002
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4700.421+0.049
TTM0.4650.428+0.037
YOY0.4740.432+0.042
3Y0.4800.426+0.054
5Y0.4730.442+0.031
10Y0.4750.455+0.020
4.5.4.2. Debt to Equity Ratio

Measures if Cementos Bio-B is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • A Debt to Equity ratio of 88.8% means that company has $0.89 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cementos Bio-B:

  • The MRQ is 0.888. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.871. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.888TTM0.871+0.017
TTM0.871YOY0.904-0.032
TTM0.8715Y0.902-0.031
5Y0.90210Y0.911-0.008
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8880.809+0.079
TTM0.8710.799+0.072
YOY0.9040.798+0.106
3Y0.9280.841+0.087
5Y0.9020.895+0.007
10Y0.9110.991-0.080
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cementos Bio-B generates.

  • Above 15 is considered overpriced but always compare Cementos Bio-B to the Building Materials industry mean.
  • A PE ratio of 17.03 means the investor is paying $17.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cementos Bio-B:

  • The EOD is 17.877. Based on the earnings, the company is fair priced.
  • The MRQ is 17.035. Based on the earnings, the company is fair priced.
  • The TTM is 10.958. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD17.877MRQ17.035+0.842
MRQ17.035TTM10.958+6.077
TTM10.958YOY10.754+0.204
TTM10.9585Y17.745-6.787
5Y17.74510Y17.674+0.071
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD17.87714.286+3.591
MRQ17.03513.176+3.859
TTM10.95814.199-3.241
YOY10.75411.967-1.213
3Y13.25413.102+0.152
5Y17.74516.546+1.199
10Y17.67418.172-0.498
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cementos Bio-B:

  • The EOD is -38.004. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -36.213. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.443. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-38.004MRQ-36.213-1.791
MRQ-36.213TTM-6.443-29.770
TTM-6.443YOY-16.327+9.884
TTM-6.4435Y3.687-10.130
5Y3.68710Y5.233-1.547
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD-38.0043.978-41.982
MRQ-36.2133.442-39.655
TTM-6.4435.411-11.854
YOY-16.3276.497-22.824
3Y-8.4594.876-13.335
5Y3.6874.128-0.441
10Y5.2334.154+1.079
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cementos Bio-B is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Building Materials industry mean).
  • A PB ratio of 1.46 means the investor is paying $1.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cementos Bio-B:

  • The EOD is 1.532. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.460. Based on the equity, the company is underpriced. +1
  • The TTM is 1.096. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.532MRQ1.460+0.072
MRQ1.460TTM1.096+0.363
TTM1.096YOY0.671+0.425
TTM1.0965Y0.821+0.275
5Y0.82110Y0.884-0.063
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD1.5321.163+0.369
MRQ1.4601.080+0.380
TTM1.0961.089+0.007
YOY0.6711.108-0.437
3Y0.8491.134-0.285
5Y0.8211.300-0.479
10Y0.8841.508-0.624
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in CLP. All numbers in thousands.

Summary
Total Assets520,605,952
Total Liabilities244,612,853
Total Stockholder Equity275,340,694
 As reported
Total Liabilities 244,612,853
Total Stockholder Equity+ 275,340,694
Total Assets = 520,605,952

Assets

Total Assets520,605,952
Total Current Assets163,674,258
Long-term Assets356,931,694
Total Current Assets
Cash And Cash Equivalents 18,501,589
Short-term Investments 1,613
Net Receivables 72,173,183
Inventory 51,079,940
Other Current Assets 629,269
Total Current Assets  (as reported)163,674,258
Total Current Assets  (calculated)142,385,594
+/- 21,288,664
Long-term Assets
Property Plant Equipment 318,970,658
Goodwill 12,484,535
Intangible Assets 2,273,503
Long-term Assets Other 64,410
Long-term Assets  (as reported)356,931,694
Long-term Assets  (calculated)333,793,106
+/- 23,138,588

Liabilities & Shareholders' Equity

Total Current Liabilities125,029,762
Long-term Liabilities119,583,091
Total Stockholder Equity275,340,694
Total Current Liabilities
Short Long Term Debt 28,849,600
Accounts payable 61,517,081
Other Current Liabilities 2,604,988
Total Current Liabilities  (as reported)125,029,762
Total Current Liabilities  (calculated)92,971,669
+/- 32,058,093
Long-term Liabilities
Long term Debt 72,346,459
Capital Lease Obligations Min Short Term Debt39,340,218
Long-term Liabilities  (as reported)119,583,091
Long-term Liabilities  (calculated)111,686,677
+/- 7,896,414
Total Stockholder Equity
Retained Earnings 147,258,505
Total Stockholder Equity (as reported)275,340,694
Total Stockholder Equity (calculated)147,258,505
+/- 128,082,189
Other
Capital Stock137,624,853
Common Stock Shares Outstanding 264,221
Net Debt 82,694,470
Net Invested Capital 376,536,753
Net Working Capital 38,644,496
Property Plant and Equipment Gross 635,227,913



6.2. Balance Sheets Structured

Currency in CLP. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
> Total Assets 
439,611,935
446,383,431
441,856,291
436,313,359
449,610,620
457,009,332
432,577,473
428,135,404
438,374,628
460,925,285
442,900,594
442,583,918
446,181,368
443,510,420
448,018,732
460,463,923
488,867,988
481,412,959
0
477,900,219
475,746,870
485,164,549
480,081,372
480,841,384
509,842,106
502,524,183
499,542,978
521,438,290
520,605,952
520,605,952521,438,290499,542,978502,524,183509,842,106480,841,384480,081,372485,164,549475,746,870477,900,2190481,412,959488,867,988460,463,923448,018,732443,510,420446,181,368442,583,918442,900,594460,925,285438,374,628428,135,404432,577,473457,009,332449,610,620436,313,359441,856,291446,383,431439,611,935
   > Total Current Assets 
113,822,336
122,293,832
119,310,364
114,905,049
127,886,918
126,908,676
101,377,340
92,495,913
108,599,110
129,522,529
111,734,144
114,154,651
119,209,205
115,455,932
111,461,083
115,041,424
150,650,101
147,014,974
134,305,293
137,552,252
133,081,728
139,796,528
134,525,604
135,119,756
160,102,823
143,652,237
142,299,676
150,061,002
163,674,258
163,674,258150,061,002142,299,676143,652,237160,102,823135,119,756134,525,604139,796,528133,081,728137,552,252134,305,293147,014,974150,650,101115,041,424111,461,083115,455,932119,209,205114,154,651111,734,144129,522,529108,599,11092,495,913101,377,340126,908,676127,886,918114,905,049119,310,364122,293,832113,822,336
       Cash And Cash Equivalents 
19,925,374
26,762,207
32,691,294
25,551,278
35,573,530
30,175,734
14,156,797
12,913,438
21,336,771
42,607,760
38,132,590
44,278,809
40,517,116
27,297,159
19,331,970
18,283,368
41,182,737
28,735,888
0
6,612,709
10,673,382
15,991,823
4,406,010
8,422,318
9,699,968
14,023,595
20,719,430
25,926,220
18,501,589
18,501,58925,926,22020,719,43014,023,5959,699,9688,422,3184,406,01015,991,82310,673,3826,612,709028,735,88841,182,73718,283,36819,331,97027,297,15940,517,11644,278,80938,132,59042,607,76021,336,77112,913,43814,156,79730,175,73435,573,53025,551,27832,691,29426,762,20719,925,374
       Short-term Investments 
73,571
5,812
21,256
2,051
1,418,277
1,439,588
2,099
14,508
3,542
11,900
45,542
2,034
329,441
2,260
2,264
2,264
2,263
2,263
0
2,249
2,248
2,248
1,808
1,808
15,709
11,305
1,613
1,613
1,613
1,6131,6131,61311,30515,7091,8081,8082,2482,2482,24902,2632,2632,2642,2642,260329,4412,03445,54211,9003,54214,5082,0991,439,5881,418,2772,05121,2565,81273,571
       Net Receivables 
55,055,118
51,340,927
40,464,525
43,721,921
49,930,537
48,341,354
39,563,722
38,664,895
45,964,341
43,551,528
30,561,137
31,378,598
36,221,947
38,619,543
47,331,124
52,532,208
56,276,058
61,245,449
63,194,906
58,695,646
47,997,326
52,774,496
56,800,599
48,080,724
72,473,333
56,418,988
54,153,047
55,986,053
72,173,183
72,173,18355,986,05354,153,04756,418,98872,473,33348,080,72456,800,59952,774,49647,997,32658,695,64663,194,90661,245,44956,276,05852,532,20847,331,12438,619,54336,221,94731,378,59830,561,13743,551,52845,964,34138,664,89539,563,72248,341,35449,930,53743,721,92140,464,52551,340,92755,055,118
       Inventory 
30,322,436
32,981,250
33,664,505
35,732,439
34,004,482
34,059,091
35,006,303
30,178,849
31,048,314
32,948,111
32,885,363
31,583,436
33,018,326
39,235,177
37,958,914
35,124,150
40,736,529
43,649,422
55,622,104
60,249,330
58,943,085
63,642,170
61,702,585
57,006,626
59,077,005
58,357,492
53,310,944
50,714,108
51,079,940
51,079,94050,714,10853,310,94458,357,49259,077,00557,006,62661,702,58563,642,17058,943,08560,249,33055,622,10443,649,42240,736,52935,124,15037,958,91439,235,17733,018,32631,583,43632,885,36332,948,11131,048,31430,178,84935,006,30334,059,09134,004,48235,732,43933,664,50532,981,25030,322,436
       Other Current Assets 
8,445,837
11,203,636
12,468,784
9,897,360
6,960,092
1,052,138
827,333
1,198,517
7,071,924
6,466,440
6,238,228
3,377,390
8,663,930
8,911,094
4,962,312
5,881,184
8,617,576
9,696,953
6,106,977
8,065,808
118,904
3,986,297
7,145,970
156,496
266,972
291,629
454,410
229,949
629,269
629,269229,949454,410291,629266,972156,4967,145,9703,986,297118,9048,065,8086,106,9779,696,9538,617,5765,881,1844,962,3128,911,0948,663,9303,377,3906,238,2286,466,4407,071,9241,198,517827,3331,052,1386,960,0929,897,36012,468,78411,203,6368,445,837
   > Long-term Assets 
0
0
0
0
0
330,100,656
331,200,133
335,639,491
329,775,518
331,402,756
331,166,450
328,429,267
326,972,163
328,054,488
336,557,649
345,422,499
338,217,887
334,397,986
0
340,347,967
342,665,142
345,368,021
345,555,768
345,721,628
349,739,282
358,871,946
357,243,302
371,377,288
356,931,694
356,931,694371,377,288357,243,302358,871,946349,739,282345,721,628345,555,768345,368,021342,665,142340,347,9670334,397,986338,217,887345,422,499336,557,649328,054,488326,972,163328,429,267331,166,450331,402,756329,775,518335,639,491331,200,133330,100,65600000
       Property Plant Equipment 
281,909,249
280,815,558
278,789,345
275,489,326
284,608,600
293,237,055
293,239,908
292,930,851
287,887,972
288,334,948
287,454,105
284,039,596
280,128,775
280,111,548
288,931,376
297,265,989
289,973,666
286,617,328
292,234,141
296,052,844
293,284,854
295,720,301
294,744,757
296,689,653
302,847,931
311,219,129
309,923,136
322,407,152
318,970,658
318,970,658322,407,152309,923,136311,219,129302,847,931296,689,653294,744,757295,720,301293,284,854296,052,844292,234,141286,617,328289,973,666297,265,989288,931,376280,111,548280,128,775284,039,596287,454,105288,334,948287,887,972292,930,851293,239,908293,237,055284,608,600275,489,326278,789,345280,815,558281,909,249
       Goodwill 
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
0
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,535012,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,535
       Long Term Investments 
17,118,214
16,884,459
17,939,312
10,146,567
11,779
33,109
11,779
11,779
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000011,77911,77933,10911,77910,146,56717,939,31216,884,45917,118,214
       Intangible Assets 
1,739,475
1,660,793
2,122,847
2,864,421
3,008,672
2,910,774
2,961,926
2,896,105
6,132,208
6,379,561
5,948,408
5,990,284
5,643,351
2,122,807
2,122,927
2,049,583
1,964,937
2,230,393
0
2,338,888
2,278,325
2,219,591
2,236,153
2,260,583
2,315,066
2,333,838
2,280,203
2,317,523
2,273,503
2,273,5032,317,5232,280,2032,333,8382,315,0662,260,5832,236,1532,219,5912,278,3252,338,88802,230,3931,964,9372,049,5832,122,9272,122,8075,643,3515,990,2845,948,4086,379,5616,132,2082,896,1052,961,9262,910,7743,008,6722,864,4212,122,8471,660,7931,739,475
       Long-term Assets Other 
0
0
0
0
0
330,100,656
331,200,133
335,639,491
52,760
52,760
52,760
52,760
512,479
46,472
46,473
46,473
46,473
38,592
0
35,095
34,969
104,827
34,969
36,969
58,715
58,715
61,540
64,410
64,410
64,41064,41061,54058,71558,71536,96934,969104,82734,96935,095038,59246,47346,47346,47346,472512,47952,76052,76052,76052,760335,639,491331,200,133330,100,65600000
> Total Liabilities 
218,998,342
221,730,947
216,897,383
209,963,276
217,775,913
223,159,548
201,047,628
194,814,298
200,524,239
219,522,124
200,975,298
199,903,222
202,569,258
198,560,358
203,236,925
208,024,581
231,643,148
248,703,439
0
236,609,228
234,092,904
240,954,948
231,901,096
226,913,350
237,977,365
228,018,941
227,119,702
250,716,998
244,612,853
244,612,853250,716,998227,119,702228,018,941237,977,365226,913,350231,901,096240,954,948234,092,904236,609,2280248,703,439231,643,148208,024,581203,236,925198,560,358202,569,258199,903,222200,975,298219,522,124200,524,239194,814,298201,047,628223,159,548217,775,913209,963,276216,897,383221,730,947218,998,342
   > Total Current Liabilities 
65,045,106
68,312,102
63,194,459
56,802,770
63,771,647
62,992,358
61,321,953
54,197,564
61,823,791
77,436,130
60,261,917
59,826,284
62,056,877
57,252,418
58,729,865
61,535,728
81,261,810
100,249,338
91,099,377
95,054,508
93,575,545
93,951,421
90,170,716
87,565,623
99,782,449
90,409,266
97,809,159
116,303,200
125,029,762
125,029,762116,303,20097,809,15990,409,26699,782,44987,565,62390,170,71693,951,42193,575,54595,054,50891,099,377100,249,33881,261,81061,535,72858,729,86557,252,41862,056,87759,826,28460,261,91777,436,13061,823,79154,197,56461,321,95362,992,35863,771,64756,802,77063,194,45968,312,10265,045,106
       Short-term Debt 
1,810,937
1,889,074
2,588,329
1,746,086
1,412,731
1,766,058
1,330,434
643,300
1,048,267
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,048,267643,3001,330,4341,766,0581,412,7311,746,0862,588,3291,889,0741,810,937
       Short Long Term Debt 
1,810,937
1,889,074
2,588,329
1,746,086
1,412,731
1,766,058
1,330,434
643,300
1,048,267
20,514,144
10,907,817
10,303,502
328,378
221,316
88,900
360,095
2,373,179
1,704,081
0
10,195,117
4,813,286
3,154,152
4,608,303
3,127,972
5,872,002
10,258,434
15,961,082
20,441,993
28,849,600
28,849,60020,441,99315,961,08210,258,4345,872,0023,127,9724,608,3033,154,1524,813,28610,195,11701,704,0812,373,179360,09588,900221,316328,37810,303,50210,907,81720,514,1441,048,267643,3001,330,4341,766,0581,412,7311,746,0862,588,3291,889,0741,810,937
       Accounts payable 
42,379,975
48,691,553
49,001,325
41,668,225
47,138,053
45,648,922
42,988,543
34,876,743
39,266,313
38,477,816
31,923,412
29,311,097
36,837,620
38,813,723
41,861,879
40,247,083
49,747,643
51,515,393
59,696,610
57,240,604
55,192,470
56,865,779
57,208,786
53,192,015
57,568,528
48,722,516
47,987,584
56,894,160
61,517,081
61,517,08156,894,16047,987,58448,722,51657,568,52853,192,01557,208,78656,865,77955,192,47057,240,60459,696,61051,515,39349,747,64340,247,08341,861,87938,813,72336,837,62029,311,09731,923,41238,477,81639,266,31334,876,74342,988,54345,648,92247,138,05341,668,22549,001,32548,691,55342,379,975
       Other Current Liabilities 
9,767,027
7,724,115
4,300,123
4,224,413
5,780,971
1,822,110
1,095,852
1,202,493
7,747,692
6,937,051
6,643,124
8,681,666
11,709,573
8,620,593
3,460,330
4,702,133
5,873,731
31,158,642
5,851,943
7,881,446
1,363,061
14,208,434
7,207,205
2,059,202
3,579,619
1,378,267
1,771,462
3,719,767
2,604,988
2,604,9883,719,7671,771,4621,378,2673,579,6192,059,2027,207,20514,208,4341,363,0617,881,4465,851,94331,158,6425,873,7314,702,1333,460,3308,620,59311,709,5738,681,6666,643,1246,937,0517,747,6921,202,4931,095,8521,822,1105,780,9714,224,4134,300,1237,724,1159,767,027
   > Long-term Liabilities 
0
0
0
0
0
160,167,190
139,725,675
140,616,734
138,700,448
142,085,994
140,713,381
140,076,938
140,512,381
141,307,940
144,507,060
146,488,853
150,381,338
148,454,101
0
141,554,720
140,517,359
147,003,527
141,730,380
139,347,727
138,194,916
137,609,675
129,310,543
134,413,798
119,583,091
119,583,091134,413,798129,310,543137,609,675138,194,916139,347,727141,730,380147,003,527140,517,359141,554,7200148,454,101150,381,338146,488,853144,507,060141,307,940140,512,381140,076,938140,713,381142,085,994138,700,448140,616,734139,725,675160,167,19000000
       Capital Lease Obligations 
0
0
0
0
0
7,562,301
7,494,083
7,804,518
7,530,387
9,078,097
8,208,632
7,373,345
7,734,580
7,395,463
15,694,466
19,334,888
22,612,470
20,464,574
0
19,941,435
20,073,698
24,423,427
22,124,962
21,358,581
20,377,435
30,236,330
29,270,648
40,178,838
39,340,218
39,340,21840,178,83829,270,64830,236,33020,377,43521,358,58122,124,96224,423,42720,073,69819,941,435020,464,57422,612,47019,334,88815,694,4667,395,4637,734,5807,373,3458,208,6329,078,0977,530,3877,804,5187,494,0837,562,30100000
> Total Stockholder Equity
219,429,304
223,567,462
223,960,070
225,396,513
230,945,984
232,926,839
230,665,677
232,448,153
237,224,874
240,744,141
241,500,624
242,269,070
243,094,123
244,444,536
244,272,563
251,903,093
256,559,920
232,051,439
0
240,636,501
240,987,916
243,528,529
247,482,841
253,229,824
271,177,149
273,836,439
271,774,926
270,071,331
275,340,694
275,340,694270,071,331271,774,926273,836,439271,177,149253,229,824247,482,841243,528,529240,987,916240,636,5010232,051,439256,559,920251,903,093244,272,563244,444,536243,094,123242,269,070241,500,624240,744,141237,224,874232,448,153230,665,677232,926,839230,945,984225,396,513223,960,070223,567,462219,429,304
   Common Stock
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
0
137,624,853
137,624,853
0
0
0
0
0
0
000000137,624,853137,624,8530137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853
   Retained Earnings 
109,289,412
113,581,418
113,830,802
115,682,149
112,444,348
114,742,670
112,401,704
114,364,926
117,621,641
120,429,678
121,944,650
122,966,111
123,986,140
125,512,477
124,850,087
131,483,142
134,483,377
109,861,346
111,253,745
113,630,824
116,774,356
121,513,630
124,166,900
127,695,503
143,710,000
147,556,271
147,073,012
141,346,625
147,258,505
147,258,505141,346,625147,073,012147,556,271143,710,000127,695,503124,166,900121,513,630116,774,356113,630,824111,253,745109,861,346134,483,377131,483,142124,850,087125,512,477123,986,140122,966,111121,944,650120,429,678117,621,641114,364,926112,401,704114,742,670112,444,348115,682,149113,830,802113,581,418109,289,412
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 000000-14,308,912-15,609,9540-10,619,176-11,590,046-15,434,760-15,548,310-17,204,902-18,202,377-18,692,794-19,034,857-18,321,894-18,068,879-17,310,390-18,021,620-19,541,626-19,360,880-19,440,684-19,123,217-27,910,489-27,495,585-27,638,809-27,484,961



6.3. Balance Sheets

Currency in CLP. All numbers in thousands.




6.4. Cash Flows

Currency in CLP. All numbers in thousands.




6.5. Income Statements

Currency in CLP. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CLP. All numbers in thousands.

Gross Profit (+$)
totalRevenue359,564,596
Cost of Revenue-222,510,394
Gross Profit137,054,202137,054,202
 
Operating Income (+$)
Gross Profit137,054,202
Operating Expense-321,457,392
Operating Income38,107,204-184,403,190
 
Operating Expense (+$)
Research Development0
Selling General Administrative72,274,027
Selling And Marketing Expenses0
Operating Expense321,457,39272,274,027
 
Net Interest Income (+$)
Interest Income1,489,632
Interest Expense-10,220,002
Other Finance Cost-873,832
Net Interest Income-9,604,202
 
Pretax Income (+$)
Operating Income38,107,204
Net Interest Income-9,604,202
Other Non-Operating Income Expenses0
Income Before Tax (EBT)40,970,36738,107,204
EBIT - interestExpense = -10,220,002
32,427,445
42,647,447
Interest Expense10,220,002
Earnings Before Interest and Taxes (EBIT)051,190,369
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax40,970,367
Tax Provision-8,571,262
Net Income From Continuing Ops32,399,10532,399,105
Net Income32,427,445
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net09,604,202
 

Technical Analysis of Cementos Bio-B
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cementos Bio-B. The general trend of Cementos Bio-B is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cementos Bio-B's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cementos Bio-B Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cementos Bio-B.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1,600 < 1,600 < 1,600.

The bearish price targets are: 1,500 > 1,499 > 1,490.

Know someone who trades $CEMENTOS? Share this with them.👇

Cementos Bio-B Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cementos Bio-B. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cementos Bio-B Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cementos Bio-B. The current macd is -9.86175903.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cementos Bio-B price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cementos Bio-B. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cementos Bio-B price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cementos Bio-B Daily Moving Average Convergence/Divergence (MACD) ChartCementos Bio-B Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cementos Bio-B. The current adx is 24.42.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cementos Bio-B shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Cementos Bio-B Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cementos Bio-B. The current sar is 1,500.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Cementos Bio-B Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cementos Bio-B. The current rsi is 61.09. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Cementos Bio-B Daily Relative Strength Index (RSI) ChartCementos Bio-B Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cementos Bio-B. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cementos Bio-B price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cementos Bio-B Daily Stochastic Oscillator ChartCementos Bio-B Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cementos Bio-B. The current cci is 45.11.

Cementos Bio-B Daily Commodity Channel Index (CCI) ChartCementos Bio-B Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cementos Bio-B. The current cmo is 30.40.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cementos Bio-B Daily Chande Momentum Oscillator (CMO) ChartCementos Bio-B Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cementos Bio-B. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Cementos Bio-B Daily Williams %R ChartCementos Bio-B Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cementos Bio-B.

Cementos Bio-B Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cementos Bio-B. The current atr is 18.65.

Cementos Bio-B Daily Average True Range (ATR) ChartCementos Bio-B Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cementos Bio-B. The current obv is 3,881,440.

Cementos Bio-B Daily On-Balance Volume (OBV) ChartCementos Bio-B Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cementos Bio-B. The current mfi is 0.6952029.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Cementos Bio-B Daily Money Flow Index (MFI) ChartCementos Bio-B Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cementos Bio-B.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Cementos Bio-B Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cementos Bio-B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.092
Ma 20Greater thanMa 501,575.000
Ma 50Greater thanMa 1001,566.104
Ma 100Greater thanMa 2001,518.402
OpenGreater thanClose1,600.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cementos Bio-B with someone you think should read this too:
  • Are you bullish or bearish on Cementos Bio-B? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cementos Bio-B? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cementos Bio-B

I send you an email if I find something interesting about Cementos Bio-B.


Comments

How you think about this?

Leave a comment

Stay informed about Cementos Bio-B.

Receive notifications about Cementos Bio-B in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.